Related Experiment Video
Updated: Jan 28, 2026

Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
Published on: June 29, 2017
Control of Klebsiella pneumoniae Infection in Mice by Using Dissolving Microarray Patches Containing Gentamicin
Aoife M Rodgers1, Maelíosa T C McCrudden1, Aaron J Courtenay1
1School of Pharmacy, Medical Biology Centre, Queens University Belfast, Belfast, United Kingdom.
Abstract:
Using a murine model of Klebsiella pneumoniae bacterial infection, we demonstrate that gentamicin dissolving microarray patches, applied to murine ears, could control K. pneumoniae infection. Mice treated with microarray patches had reduced bacterial burden in the nasal-associated lymphoid tissue and lungs compared with their untreated counterparts. This proof of concept study represents the first published data on the in vivo delivery of the antibiotic gentamicin via dissolving microarray patches, resulting in the control of bacterial infection.
Insights
Gentamicin dissolving microarray patches effectively controlled Klebsiella pneumoniae infections in mice. This novel approach reduced bacterial burden in key tissues, showing promise for new antibiotic delivery methods.
Area of Science:
- Microbiology
- Pharmacology
- Biomedical Engineering
Background:
- Klebsiella pneumoniae is a significant cause of bacterial infections.
- Effective antibiotic delivery remains a challenge for treating localized infections.
- Novel drug delivery systems are needed to improve therapeutic outcomes.
Purpose of the Study:
- To investigate the efficacy of gentamicin dissolving microarray patches for treating Klebsiella pneumoniae infection.
- To evaluate the in vivo delivery of gentamicin using microarray patch technology.
- To establish a proof of concept for this novel antimicrobial delivery system.
Main Methods:
- A murine model of Klebsiella pneumoniae infection was utilized.
- Gentamicin was administered via dissolving microarray patches applied to murine ears.
- Bacterial burden was assessed in nasal-associated lymphoid tissue and lungs.
Main Results:
- Microarray patch application of gentamicin significantly controlled Klebsiella pneumoniae infection.
- Treated mice exhibited reduced bacterial burden in the nasal-associated lymphoid tissue and lungs compared to controls.
- This study provides the first in vivo data on gentamicin delivery via dissolving microarray patches.
Conclusions:
- Dissolving microarray patches offer a viable method for in vivo delivery of gentamicin.
- This technology demonstrates potential for controlling bacterial infections like Klebsiella pneumoniae.
- Further research into microarray patch applications for infectious diseases is warranted.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Long-patch Base Excision Repair
DNA Microarrays
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

